|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
1R01CA208756-01
|
$518,165
|
$259,083
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
|
(PQB-4) Opposing Effects of the SASP in Cancer Progression
|
5R01CA184572-03
|
$329,925
|
$112,175
|
HERBIG, UTZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
|
(PQD1) Clonal heterogeneity and targeted therapy resistance in melanoma
|
5R01CA185072-03
|
$351,883
|
$351,883
|
SEKULIC, ALEKSANDAR
|
MAYO CLINIC ARIZONA
|
|
|
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells
|
5R01CA185151-03
|
$696,509
|
$696,509
|
NOVINA, CARL
|
DANA-FARBER CANCER INST
|
|
|
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis
|
5R01CA185189-03
|
$483,693
|
$483,693
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
(PQD5) Predicting Anti-Cancer Efficacy through Tumor Profiling
|
5R01CA185353-03
|
$405,890
|
$405,890
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-07
|
$1,293,750
|
$194,063
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
1F30CA203270-01
|
$43,576
|
$43,576
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A comparison of interventions to teach patients skin self-examination
|
2R01CA154908-06A1
|
$619,209
|
$619,209
|
ROBINSON, JUNE
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
A High-Throughput Model for Human Melanoma
|
5R01CA121118-08
|
$247,340
|
$247,340
|
HOLMEN, SHERI
|
UNIVERSITY OF UTAH
|
|
|
A NOVEL DRUGGABLE GENETIC VULNERABILITY PATHWAY IN MELANOMA
|
1R01CA200919-01
|
$381,822
|
$381,822
|
WAJAPEYEE, NARENDRA
|
YALE UNIVERSITY
|
|
|
A novel IL-2 biologic and tumor immunity
|
1R21CA195334-01A1
|
$166,931
|
$166,931
|
MALEK, THOMAS
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
A novel in vivo model system of melanoma using a human-mouse neural crest cell chimera
|
5F32CA196065-02
|
$56,118
|
$56,118
|
WERT, KATHERINE
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
|
|
A novel NKG2D-specific BiTE cancer immunotherapy
|
4R01CA164178-04
|
$336,150
|
$168,075
|
SENTMAN, CHARLES
|
DARTMOUTH COLLEGE
|
|
|
A novel preclinical model of spontaneous metastasis
|
ZIA BC 011167
|
$470,860
|
$447,317
|
Merlino, Glenn
|
CCR (NCI)
|
|
|
A research and training program for junior clinicians in treating metastatic mela
|
4K24CA172123-04
|
$156,084
|
$156,084
|
KLUGER, HARRIET
|
YALE UNIVERSITY
|
|
|
A role for AKT2 in BRAFV600E melanoma initiation, progression, and response to therapy
|
1F31CA210312-01
|
$39,312
|
$39,312
|
MCREE, SIOBHAN
|
TUFTS UNIVERSITY BOSTON
|
|
|
A role for c-Abl/Arg in melanoma progression
|
4R01CA166499-05
|
$308,604
|
$308,604
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
|
A Self-Regulation Approach to an Indoor Tanning Intervention for Frequent Users
|
5K07CA175115-03
|
$137,183
|
$137,183
|
STAPLETON, JEROD
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
$478,533
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S1
|
$31,250
|
$1,875
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
$29,998
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S3
|
$200,000
|
$12,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Adaptive regulation of cancer cell fate following oncogene inhibition
|
5K99CA194163-02
|
$120,183
|
$120,183
|
FALLAHI-SICHANI, MOHAMMAD
|
HARVARD MEDICAL SCHOOL
|
|
|
Adoptive Cell Therapy with Rejuvenated Antigen-Specific T Cells
|
5K08CA197966-03
|
$174,960
|
$174,960
|
ITO, FUMITO
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,726,433
|
$1,553,790
|
Rosenberg, Steven
|
CCR (NCI)
|
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
4U24CA180921-04
|
$634,033
|
$126,807
|
JACOBSON, REBECCA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Allotransplant for DOCK8 deficiency
|
ZIA BC 011374
|
$441,849
|
$220,925
|
Hickstein, Dennis
|
CCR (NCI)
|
|
|
An Internet-Based Behavioral Intervention for Individuals Diagnosed with Melanoma
|
5R01CA171666-03
|
$492,260
|
$492,260
|
COUPS, ELLIOT
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$40,597
|
Barr, Frederic
|
CCR (NCI)
|
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$1,011,302
|
$303,391
|
DuBois, Wendy
|
CCR (NCI)
|
|
|
ANOIKIS EFFECTORS AS DRIVERS OF METASTATIC MELANOMA
|
1R21CA195077-01A1
|
$217,826
|
$217,826
|
WAJAPEYEE, NARENDRA
|
YALE UNIVERSITY
|
|
|
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
|
4R01CA092160-15
|
$297,491
|
$148,746
|
TIGYI, GABOR
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$2,321,426
|
$348,214
|
Berzofsky, Jay
|
CCR (NCI)
|
|
|
Automated Image Guidance for Diagnosing Skin Cancer With Confocal Microscopy
|
5R01CA199673-02
|
$618,809
|
$618,809
|
RAJADHYAKSHA, MILIND
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Automated Platform for Fixed Tissue Microdissection
|
1R44CA199194-01A1
|
$265,643
|
$265,643
|
KARSTEN, STANISLAV
|
NEUROINDX INC.
|
|
|
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
|
5R01CA198105-02
|
$401,456
|
$200,728
|
JIANG, AIMIN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
B7-H1 Signaling in Ovarian Cancer
|
4R01CA164122-05
|
$310,213
|
$124,085
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
|
BACH2 in Melanoma Development and Resistance
|
1K22CA197058-01
|
$177,344
|
$177,344
|
KARRETH, FLORIAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,732,997
|
$2,209,950
|
Custer, Mary
|
CCR (NCI)
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$2,360
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$3,418
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$2,378
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$9,999
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$2,684
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$65,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Bifunctional Antibodies for Melanoma Therapy
|
5R01CA177719-03
|
$442,736
|
$442,736
|
GLAZER, PETER
|
YALE UNIVERSITY
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
$79,146
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Biomarkers and Resistance Mechanisms in Melanoma T-cell Therapy
|
5R01CA184845-03
|
$337,726
|
$337,726
|
HWU, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Biomimetic artificial antigen presenting cells for melanoma immunotherapy
|
1F31CA214147-01
|
$43,576
|
$43,576
|
MEYER, RANDALL
|
JOHNS HOPKINS UNIVERSITY
|
|
Total relevant funding to Melanoma for this search: $142,932,957
|
